T1	Intervention 22 47	gonadotropin combinations
T2	Intervention 140 182	human recombinant FSH/human recombinant LH
T3	Intervention 202 247	highly purified human menopausal gonadotropin
T4	Intervention 560 624	human recombinant FSH (r-hFSH) plus human recombinant LH (r-hLH)
T5	Intervention 645 715	highly purified human menopausal gonadotropin (hMG-HP) urinary extract
T6	Intervention 912 930	150 IU hMG-HP (150
T7	Intervention 988 1010	150IU r-hFSH/75IU rhLH
T8	Intervention 1125 1148	hMG-HP or r-hFSH/r-hLH.
T9	Intervention 1507 1526	70% of r-hFSH/r-hLH
T10	Intervention 1572 1578	88% in
T11	Intervention 1611 1629	PR in r-hFSH/r-hLH
T12	Intervention 1658 1673	23.3% in hMG-HP
T13	Intervention 1787 1798	superiority
T14	Intervention 1805 1816	compared to
T15	Intervention 1824 1834	supporting
